Overview

A Study of Pre-operative Metformin in Prostate Cancer

Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study will investigate the effect of neoadjuvant metformin therapy in the inhibition of growth and proliferation of prostate cancer cells prior to radical prostatectomy.
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Jewish General Hospital
Treatments:
Metformin